Global and China Hepatitis Vaccine Market Insights, Forecast to 2027

Publisher Name :
Date: 24-Dec-2021
No. of pages: 142
Inquire Before Buying

Hepatitis Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Hepatitis Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Hepatitis A Vaccines

- Hepatitis B Vaccines

Segment by Application

- Children

- Adult

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- GSK

- NCPC

- Merck

- Bio Kangtai

- Dynavax

- Hissen

- KM Biologics

- LG Life Sciences

- Serum Institute

- Sanofi

- Sinovac

- Zhejiang Pukang

- IMBCA

- ChangSheng

Global and China Hepatitis Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Hepatitis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis Vaccine Market Size Growth Rate by Type
1.2.2 Hepatitis A Vaccines
1.2.3 Hepatitis B Vaccines
1.3 Market by Application
1.3.1 Global Hepatitis Vaccine Market Size Growth Rate by Application
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Hepatitis Vaccine Revenue 2016-2027
2.1.2 Global Hepatitis Vaccine Sales 2016-2027
2.2 Global Hepatitis Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hepatitis Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Hepatitis Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hepatitis Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hepatitis Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hepatitis Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Hepatitis Vaccine Revenue Forecast by Region (2022-2027)
3 Global Hepatitis Vaccine Competitor Landscape by Players
3.1 Global Top Hepatitis Vaccine Manufacturers by Sales
3.1.1 Global Hepatitis Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Hepatitis Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hepatitis Vaccine Manufacturers by Revenue
3.2.1 Key Hepatitis Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hepatitis Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Hepatitis Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hepatitis Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hepatitis Vaccine Revenue in 2020
3.2.6 Global Hepatitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hepatitis Vaccine Price by Manufacturers
3.4 Global Hepatitis Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Hepatitis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepatitis Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Hepatitis Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Hepatitis Vaccine Market Size by Type (2016-2021)
4.1.1 Global Hepatitis Vaccine Sales by Type (2016-2021)
4.1.2 Global Hepatitis Vaccine Revenue by Type (2016-2021)
4.1.3 Hepatitis Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hepatitis Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Hepatitis Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Hepatitis Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Hepatitis Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Hepatitis Vaccine Market Size by Application (2016-2021)
5.1.1 Global Hepatitis Vaccine Sales by Application (2016-2021)
5.1.2 Global Hepatitis Vaccine Revenue by Application (2016-2021)
5.1.3 Hepatitis Vaccine Price by Application (2016-2021)
5.2 Hepatitis Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Hepatitis Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Hepatitis Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Hepatitis Vaccine Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Hepatitis Vaccine Market Size YoY Growth 2016-2027
6.1.1 China Hepatitis Vaccine Sales YoY Growth 2016-2027
6.1.2 China Hepatitis Vaccine Revenue YoY Growth 2016-2027
6.1.3 China Hepatitis Vaccine Market Share in Global Market 2016-2027
6.2 China Hepatitis Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Hepatitis Vaccine Players by Sales (2016-2021)
6.2.2 China Top Hepatitis Vaccine Players by Revenue (2016-2021)
6.3 China Hepatitis Vaccine Historic Market Review by Type (2016-2021)
6.3.1 China Hepatitis Vaccine Sales Market Share by Type (2016-2021)
6.3.2 China Hepatitis Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 China Hepatitis Vaccine Price by Type (2016-2021)
6.4 China Hepatitis Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Hepatitis Vaccine Sales Forecast by Type (2022-2027)
6.4.2 China Hepatitis Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 China Hepatitis Vaccine Price Forecast by Type (2022-2027)
6.5 China Hepatitis Vaccine Historic Market Review by Application (2016-2021)
6.5.1 China Hepatitis Vaccine Sales Market Share by Application (2016-2021)
6.5.2 China Hepatitis Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 China Hepatitis Vaccine Price by Application (2016-2021)
6.6 China Hepatitis Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Hepatitis Vaccine Sales Forecast by Application (2022-2027)
6.6.2 China Hepatitis Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 China Hepatitis Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Hepatitis Vaccine Market Size YoY Growth 2016-2027
7.2 North America Hepatitis Vaccine Market Facts & Figures by Country
7.2.1 North America Hepatitis Vaccine Sales by Country (2016-2021)
7.2.2 North America Hepatitis Vaccine Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Hepatitis Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hepatitis Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Hepatitis Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Hepatitis Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Hepatitis Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Hepatitis Vaccine Market Facts & Figures by Country
9.2.1 Europe Hepatitis Vaccine Sales by Country (2016-2021)
9.2.2 Europe Hepatitis Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Hepatitis Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Hepatitis Vaccine Market Facts & Figures by Country
10.2.1 Latin America Hepatitis Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Hepatitis Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Hepatitis Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hepatitis Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Hepatitis Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hepatitis Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Hepatitis Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 NCPC
12.2.1 NCPC Corporation Information
12.2.2 NCPC Description and Business Overview
12.2.3 NCPC Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 NCPC Hepatitis Vaccine Products Offered
12.2.5 NCPC Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Hepatitis Vaccine Products Offered
12.3.5 Merck Recent Development
12.4 Bio Kangtai
12.4.1 Bio Kangtai Corporation Information
12.4.2 Bio Kangtai Description and Business Overview
12.4.3 Bio Kangtai Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bio Kangtai Hepatitis Vaccine Products Offered
12.4.5 Bio Kangtai Recent Development
12.5 Dynavax
12.5.1 Dynavax Corporation Information
12.5.2 Dynavax Description and Business Overview
12.5.3 Dynavax Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Dynavax Hepatitis Vaccine Products Offered
12.5.5 Dynavax Recent Development
12.6 Hissen
12.6.1 Hissen Corporation Information
12.6.2 Hissen Description and Business Overview
12.6.3 Hissen Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Hissen Hepatitis Vaccine Products Offered
12.6.5 Hissen Recent Development
12.7 KM Biologics
12.7.1 KM Biologics Corporation Information
12.7.2 KM Biologics Description and Business Overview
12.7.3 KM Biologics Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 KM Biologics Hepatitis Vaccine Products Offered
12.7.5 KM Biologics Recent Development
12.8 LG Life Sciences
12.8.1 LG Life Sciences Corporation Information
12.8.2 LG Life Sciences Description and Business Overview
12.8.3 LG Life Sciences Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 LG Life Sciences Hepatitis Vaccine Products Offered
12.8.5 LG Life Sciences Recent Development
12.9 Serum Institute
12.9.1 Serum Institute Corporation Information
12.9.2 Serum Institute Description and Business Overview
12.9.3 Serum Institute Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Serum Institute Hepatitis Vaccine Products Offered
12.9.5 Serum Institute Recent Development
12.10 Sanofi
12.10.1 Sanofi Corporation Information
12.10.2 Sanofi Description and Business Overview
12.10.3 Sanofi Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Sanofi Hepatitis Vaccine Products Offered
12.10.5 Sanofi Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GSK Hepatitis Vaccine Products Offered
12.11.5 GSK Recent Development
12.12 Zhejiang Pukang
12.12.1 Zhejiang Pukang Corporation Information
12.12.2 Zhejiang Pukang Description and Business Overview
12.12.3 Zhejiang Pukang Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhejiang Pukang Products Offered
12.12.5 Zhejiang Pukang Recent Development
12.13 IMBCA
12.13.1 IMBCA Corporation Information
12.13.2 IMBCA Description and Business Overview
12.13.3 IMBCA Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 IMBCA Products Offered
12.13.5 IMBCA Recent Development
12.14 ChangSheng
12.14.1 ChangSheng Corporation Information
12.14.2 ChangSheng Description and Business Overview
12.14.3 ChangSheng Hepatitis Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 ChangSheng Products Offered
12.14.5 ChangSheng Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hepatitis Vaccine Industry Trends
13.2 Hepatitis Vaccine Market Drivers
13.3 Hepatitis Vaccine Market Challenges
13.4 Hepatitis Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hepatitis Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Hepatitis Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Hepatitis A Vaccines
Table 3. Major Manufacturers of Hepatitis B Vaccines
Table 4. Global Hepatitis Vaccine Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Hepatitis Vaccine Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Hepatitis Vaccine Sales by Regions (2016-2021) & (K Units)
Table 7. Global Hepatitis Vaccine Sales Market Share by Regions (2016-2021)
Table 8. Global Hepatitis Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Hepatitis Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Hepatitis Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Hepatitis Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Hepatitis Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Hepatitis Vaccine Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Hepatitis Vaccine Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Hepatitis Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 16. Hepatitis Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Hepatitis Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Global Hepatitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Hepatitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis Vaccine as of 2020)
Table 20. Key Manufacturers Hepatitis Vaccine Price (2016-2021) (US$/Unit)
Table 21. Hepatitis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hepatitis Vaccine Product Type
Table 23. Date of International Manufacturers Enter into Hepatitis Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Hepatitis Vaccine Sales by Type (2016-2021) (K Units)
Table 26. Global Hepatitis Vaccine Sales Share by Type (2016-2021)
Table 27. Global Hepatitis Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Hepatitis Vaccine Revenue Share by Type (2016-2021)
Table 29. Hepatitis Vaccine Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Hepatitis Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Hepatitis Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Hepatitis Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Hepatitis Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Hepatitis Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Hepatitis Vaccine Sales by Application (2016-2021) (K Units)
Table 36. Global Hepatitis Vaccine Sales Share by Application (2016-2021)
Table 37. Global Hepatitis Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Hepatitis Vaccine Revenue Share by Application (2016-2021)
Table 39. Hepatitis Vaccine Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Hepatitis Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Hepatitis Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Hepatitis Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Hepatitis Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Hepatitis Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. China Hepatitis Vaccine Sales (K Units) of Key Companies (2016-2021)
Table 46. China Hepatitis Vaccine Sales Share by Company (2016-2021)
Table 47. China Hepatitis Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 48. China Hepatitis Vaccine Revenue Share by Company (2016-2021)
Table 49. China Hepatitis Vaccine Sales (K Units) by Type (2016-2021)
Table 50. China Hepatitis Vaccine Sales Share by Type (2016-2021)
Table 51. China Hepatitis Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Hepatitis Vaccine Price (US$/Unit) by Type (2016-2021)
Table 53. China Hepatitis Vaccine Sales (K Units) by Type (2022-2027)
Table 54. China Hepatitis Vaccine Sales Share by Type (2022-2027)
Table 55. China Hepatitis Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Hepatitis Vaccine Revenue Share by Type (2022-2027)
Table 57. China Hepatitis Vaccine Price (US$/Unit) by Type (2022-2027)
Table 58. China Hepatitis Vaccine Sales (K Units) by Application (2016-2021)
Table 59. China Hepatitis Vaccine Sales Share by Application (2016-2021)
Table 60. China Hepatitis Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Hepatitis Vaccine Price (US$/Unit) by Application (2016-2021)
Table 62. China Hepatitis Vaccine Sales (K Units) by Application (2022-2027)
Table 63. China Hepatitis Vaccine Sales Share by Application (2022-2027)
Table 64. China Hepatitis Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Hepatitis Vaccine Revenue Share by Application (2022-2027)
Table 66. China Hepatitis Vaccine Price (US$/Unit) by Application (2022-2027)
Table 67. North America Hepatitis Vaccine Sales by Country (2016-2021) & (K Units)
Table 68. North America Hepatitis Vaccine Sales Market Share by Country (2016-2021)
Table 69. North America Hepatitis Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Hepatitis Vaccine Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Hepatitis Vaccine Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Hepatitis Vaccine Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Hepatitis Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Hepatitis Vaccine Revenue Market Share by Region (2016-2021)
Table 75. Europe Hepatitis Vaccine Sales by Country (2016-2021) & (K Units)
Table 76. Europe Hepatitis Vaccine Sales Market Share by Country (2016-2021)
Table 77. Europe Hepatitis Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Hepatitis Vaccine Revenue Market Share by Country (2016-2021)
Table 79. Latin America Hepatitis Vaccine Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Hepatitis Vaccine Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Hepatitis Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Hepatitis Vaccine Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Hepatitis Vaccine Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Hepatitis Vaccine Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Hepatitis Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Hepatitis Vaccine Revenue Market Share by Country (2016-2021)
Table 87. GSK Corporation Information
Table 88. GSK Description and Business Overview
Table 89. GSK Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. GSK Hepatitis Vaccine Product
Table 91. GSK Recent Development
Table 92. NCPC Corporation Information
Table 93. NCPC Description and Business Overview
Table 94. NCPC Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 95. NCPC Product
Table 96. NCPC Recent Development
Table 97. Merck Corporation Information
Table 98. Merck Description and Business Overview
Table 99. Merck Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 100. Merck Product
Table 101. Merck Recent Development
Table 102. Bio Kangtai Corporation Information
Table 103. Bio Kangtai Description and Business Overview
Table 104. Bio Kangtai Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. Bio Kangtai Product
Table 106. Bio Kangtai Recent Development
Table 107. Dynavax Corporation Information
Table 108. Dynavax Description and Business Overview
Table 109. Dynavax Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. Dynavax Product
Table 111. Dynavax Recent Development
Table 112. Hissen Corporation Information
Table 113. Hissen Description and Business Overview
Table 114. Hissen Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Hissen Product
Table 116. Hissen Recent Development
Table 117. KM Biologics Corporation Information
Table 118. KM Biologics Description and Business Overview
Table 119. KM Biologics Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. KM Biologics Product
Table 121. KM Biologics Recent Development
Table 122. LG Life Sciences Corporation Information
Table 123. LG Life Sciences Description and Business Overview
Table 124. LG Life Sciences Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. LG Life Sciences Product
Table 126. LG Life Sciences Recent Development
Table 127. Serum Institute Corporation Information
Table 128. Serum Institute Description and Business Overview
Table 129. Serum Institute Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. Serum Institute Product
Table 131. Serum Institute Recent Development
Table 132. Sanofi Corporation Information
Table 133. Sanofi Description and Business Overview
Table 134. Sanofi Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Sanofi Product
Table 136. Sanofi Recent Development
Table 137. Sinovac Corporation Information
Table 138. Sinovac Description and Business Overview
Table 139. Sinovac Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Sinovac Product
Table 141. Sinovac Recent Development
Table 142. Zhejiang Pukang Corporation Information
Table 143. Zhejiang Pukang Description and Business Overview
Table 144. Zhejiang Pukang Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Zhejiang Pukang Product
Table 146. Zhejiang Pukang Recent Development
Table 147. IMBCA Corporation Information
Table 148. IMBCA Description and Business Overview
Table 149. IMBCA Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. IMBCA Product
Table 151. IMBCA Recent Development
Table 152. ChangSheng Corporation Information
Table 153. ChangSheng Description and Business Overview
Table 154. ChangSheng Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 155. ChangSheng Product
Table 156. ChangSheng Recent Development
Table 157. Hepatitis Vaccine Market Trends
Table 158. Hepatitis Vaccine Market Drivers
Table 159. Hepatitis Vaccine Market Challenges
Table 160. Hepatitis Vaccine Market Restraints
Table 161. Hepatitis Vaccine Customers List
Table 162. Hepatitis Vaccine Distributors List
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis Vaccine Product Picture
Figure 2. Global Hepatitis Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Hepatitis A Vaccines Product Picture
Figure 4. Hepatitis B Vaccines Product Picture
Figure 5. Global Hepatitis Vaccine Sales Market Share by Application in 2020 & 2027
Figure 6. Children
Figure 7. Adult
Figure 8. Hepatitis Vaccine Report Years Considered
Figure 9. Global Hepatitis Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hepatitis Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global Hepatitis Vaccine Sales 2016-2027 (K Units)
Figure 12. Global Hepatitis Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Hepatitis Vaccine Sales Market Share by Region (2016-2021)
Figure 14. Global Hepatitis Vaccine Sales Market Share by Region in 2020
Figure 15. Global Hepatitis Vaccine Revenue Market Share by Region (2016-2021)
Figure 16. Global Hepatitis Vaccine Revenue Market Share by Region in 2020
Figure 17. Global Hepatitis Vaccine Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Hepatitis Vaccine Revenue in 2020
Figure 19. Hepatitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Hepatitis Vaccine Sales Market Share by Type (2016-2021)
Figure 21. Global Hepatitis Vaccine Sales Market Share by Type in 2020
Figure 22. Global Hepatitis Vaccine Revenue Market Share by Type (2016-2021)
Figure 23. Global Hepatitis Vaccine Revenue Market Share by Type in 2020
Figure 24. Global Hepatitis Vaccine Sales Market Share by Application (2016-2021)
Figure 25. Global Hepatitis Vaccine Sales Market Share by Application in 2020
Figure 26. Global Hepatitis Vaccine Revenue Market Share by Application (2016-2021)
Figure 27. Global Hepatitis Vaccine Revenue Market Share by Application in 2020
Figure 28. China Hepatitis Vaccine Sales Growth Rate 2016-2027 (K Units)
Figure 29. China Hepatitis Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Hepatitis Vaccine Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Hepatitis Vaccine Players Market Share by Revenue in Hepatitis Vaccine in 2020
Figure 32. China Hepatitis Vaccine Revenue Share by Type (2016-2021)
Figure 33. China Hepatitis Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Hepatitis Vaccine Revenue Share by Application (2016-2021)
Figure 35. China Hepatitis Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Hepatitis Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 37. North America Hepatitis Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Hepatitis Vaccine Sales Market Share by Country in 2020
Figure 39. North America Hepatitis Vaccine Revenue Market Share by Country in 2020
Figure 40. United States Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 41. United States Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 43. Canada Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Hepatitis Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 45. Europe Hepatitis Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Hepatitis Vaccine Sales Market Share by Country in 2020
Figure 47. Europe Hepatitis Vaccine Revenue Market Share by Country in 2020
Figure 48. Germany Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 49. Germany Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 51. France Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 53. U.K. Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 55. Italy Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 57. Russia Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Hepatitis Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 59. Asia Pacific Hepatitis Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Hepatitis Vaccine Sales Market Share by Region in 2020
Figure 61. Asia Pacific Hepatitis Vaccine Revenue Market Share by Region in 2020
Figure 62. China Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 63. China Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 65. Japan Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 67. South Korea Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 69. India Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 71. Australia Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. China Taiwan Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 73. China Taiwan Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 75. Indonesia Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 77. Thailand Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 79. Malaysia Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Latin America Hepatitis Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 81. Latin America Hepatitis Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 82. Latin America Hepatitis Vaccine Sales Market Share by Country in 2020
Figure 83. Latin America Hepatitis Vaccine Revenue Market Share by Country in 2020
Figure 84. Mexico Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 85. Mexico Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Brazil Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 87. Brazil Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Argentina Hepatitis Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 89. Argentina Hepatitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90.
  • Global Thymosin Market Insights and Forecast to 2028
    Published: 05-May-2022        Price: US 4900 Onwards        Pages: 125
    Thymosin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Thymosin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Thymosin Alpha-1 - Thymosin Alpha-2 - Thymosin Beta-4 Segment by Application - Emphysema......
  • Global Thymosin a1 Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
    Published: 28-Apr-2022        Price: US 3480 Onwards        Pages: 98
    The Thymosin a1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our (Global Info Resea......
  • Global Thymosin Beta 4 Antibody Market Insights, Forecast to 2028
    Published: 28-Apr-2022        Price: US 4900 Onwards        Pages: 110
    Thymosin Beta 4 Antibody market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Thymosin Beta 4 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Human - Animal Segment by Application - ELISA - Immunohistoch......
  • Hepatitis Drugs Markets in China
    Published: 05-Apr-2022        Price: US 4000 Onwards        Pages: 196
    China's demand for Hepatitis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industr......
  • Hepatitis Drugs Companies in China
    Published: 05-Apr-2022        Price: US 1800 Onwards        Pages: 63
    This study focuses on China's Hepatitis Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of ......
  • Hepatitis Drugs Industry Forecasts - China Focus
    Published: 05-Apr-2022        Price: US 1800 Onwards        Pages: 81
    This study focuses on China's Hepatitis Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. The......
  • 2022-2030 Report on Global Hepatitis A Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 14-Mar-2022        Price: US 2500 Onwards        Pages: 105
    This report studies the Hepatitis A Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Government Institution, Private Sector, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Gsk, Merck, Sanofi, Sinovac, Zhejiang Pukang, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global ma......
  • Global Hepatitis A Vaccine Market Insights, Forecast to 2028
    Published: 12-Mar-2022        Price: US 4900 Onwards        Pages: 145
    Market Analysis and Insights: Global Hepatitis A Vaccine Market Due to the COVID-19 pandemic, the global Hepatitis A Vaccine market size is estimated to be worth US$ 735.86 million in 2022 and is forecast to a readjusted size of US$ 840.42 million by 2028 with a CAGR of 2.24% during the review period. The global key manufacturers of Hepatitis A Vaccine include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, and AIM Vaccine etc......
  • Global Thymosin a1 Market Insights, Forecast to 2028
    Published: 09-Mar-2022        Price: US 4900 Onwards        Pages: 88
    Thymosin a1 market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Thymosin a1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Freeze-dried Powder - Injection Segment by Application - Hospital Pharmacies - Retail P......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs